Chemours Company Faces Securities Fraud Lawsuit Following 18.63% Stock Drop
Oct 20, 2026
The Law Offices of Frank R. Cruz filed a securities fraud class action against Chemours after its stock fell 18.63% due to revised guidance on Opteon product demand. Investors have until December 7, 2026, to file as lead plaintiff.
Show all 32 updates